Sandra A. Jablonski

4.0k total citations · 1 hit paper
41 papers, 3.1k citations indexed

About

Sandra A. Jablonski is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Sandra A. Jablonski has authored 41 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 15 papers in Cell Biology and 14 papers in Oncology. Recurrent topics in Sandra A. Jablonski's work include Microtubule and mitosis dynamics (14 papers), Ubiquitin and proteasome pathways (6 papers) and CAR-T cell therapy research (6 papers). Sandra A. Jablonski is often cited by papers focused on Microtubule and mitosis dynamics (14 papers), Ubiquitin and proteasome pathways (6 papers) and CAR-T cell therapy research (6 papers). Sandra A. Jablonski collaborates with scholars based in United States, United Kingdom and Russia. Sandra A. Jablonski's co-authors include Tim J. Yen, Erica A. Golemis, Elizabeth P. Henske, Tiffiney R. Hartman, Elena N. Pugacheva, Gordon K. Chan, Song‐Tao Liu, Casey D. Morrow, James C. Hittle and Valery Sudakin and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Sandra A. Jablonski

40 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium

2007 687 citations Elena N. Pugacheva, Sandra A. Jablonski et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra A. Jablonski United States	22	2.4k	1.5k	592	512	434	41	3.1k
Violaine Moreau France	28	1.7k 0.7×	1.7k 1.1×	444 0.8×	338 0.7×	137 0.3×	59	3.2k
Stephen Kearsey United Kingdom	37	4.2k 1.8×	951 0.6×	537 0.9×	536 1.0×	527 1.2×	78	4.8k
Elias Coutavas United States	21	2.7k 1.1×	546 0.4×	288 0.5×	523 1.0×	133 0.3×	28	3.3k
Annette M.G. Dirac Netherlands	17	3.7k 1.5×	477 0.3×	473 0.8×	1.2k 2.4×	142 0.3×	18	4.3k
Peter Baum United States	22	2.1k 0.9×	815 0.5×	766 1.3×	450 0.9×	238 0.5×	38	3.9k
Daniele Fachinetti France	31	3.0k 1.2×	1.0k 0.7×	521 0.9×	501 1.0×	1.3k 3.0×	58	3.5k
Harold E Varmus United States	18	2.4k 1.0×	339 0.2×	680 1.1×	776 1.5×	279 0.6×	25	3.7k
Rimma Belotserkovskaya United Kingdom	17	3.2k 1.3×	325 0.2×	295 0.5×	589 1.2×	272 0.6×	20	3.4k
Katheryn Meek United States	43	4.6k 1.9×	447 0.3×	382 0.6×	1.8k 3.5×	236 0.5×	83	5.6k
Benoit Coulombe Canada	35	3.4k 1.4×	282 0.2×	545 0.9×	505 1.0×	140 0.3×	96	4.1k

Countries citing papers authored by Sandra A. Jablonski

Since Specialization

Citations

This map shows the geographic impact of Sandra A. Jablonski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra A. Jablonski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra A. Jablonski more than expected).

Fields of papers citing papers by Sandra A. Jablonski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra A. Jablonski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra A. Jablonski. The network helps show where Sandra A. Jablonski may publish in the future.

Co-authorship network of co-authors of Sandra A. Jablonski

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra A. Jablonski. A scholar is included among the top collaborators of Sandra A. Jablonski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra A. Jablonski. Sandra A. Jablonski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malchiodi, Zoe X., Allison A. Fitzgerald, Shangzi Wang, et al.. (2021). Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance. Cancer Immunology Research. 9(4). 386–400. 14 indexed citations

Fitzgerald, Allison A., Shangzi Wang, Veena R. Agarwal, et al.. (2021). DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer. 9(11). e002837–e002837. 53 indexed citations

Sherman, Thomas D., Luciane T. Kagohara, Raymond Cheng, et al.. (2019). CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancer. PLoS Computational Biology. 14(4). e1006935–e1006935. 1 indexed citations

Aldeghaither, Dalal, David J. Zahavi, Joseph C. Murray, et al.. (2018). A Mechanism of Resistance to Antibody-Targeted Immune Attack. Cancer Immunology Research. 7(2). 230–243. 34 indexed citations

Shuptrine, Casey W., Elana J. Fertig, Sandra A. Jablonski, et al.. (2017). An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection. Cancer Immunology Immunotherapy. 66(12). 1529–1544. 12 indexed citations

Smith, Jill P., Shangzi Wang, Sandeep Nadella, Sandra A. Jablonski, & Louis M. Weiner. (2017). Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunology Immunotherapy. 67(2). 195–207. 30 indexed citations

Varghese, Rency S., Yi Zhao, Yongwei Zhang, et al.. (2017). Protein network construction using reverse phase protein array data. Methods. 124. 89–99. 2 indexed citations

Zhang, Yongwei, Sandra A. Jablonski, Ilya G. Serebriiskii, et al.. (2017). RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. BIO-PROTOCOL. 7(15).

Zhou, Yan, S. E. Lysenko, Linara Gabitova, et al.. (2016). Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer. Clinical Cancer Research. 22(24). 6153–6163. 47 indexed citations

10.

Zhang, Yongwei, Sandra A. Jablonski, Ilya G. Serebriiskii, et al.. (2015). Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation. Oncogene. 35(13). 1643–1656. 21 indexed citations

11.

Murray, Joseph C., Dalal Aldeghaither, Shangzi Wang, et al.. (2014). c-Abl Modulates Tumor Cell Sensitivity to Antibody-Dependent Cellular Cytotoxicity. Cancer Immunology Research. 2(12). 1186–1198. 12 indexed citations

12.

Surana, Rishi, Shangzi Wang, Wei Xu, Sandra A. Jablonski, & Louis M. Weiner. (2014). IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model. Cancer Immunology Research. 2(11). 1103–1112. 18 indexed citations

13.

Du, Jian, Sandra A. Jablonski, Tim J. Yen, & Gregory J. Hannon. (2008). Astrin regulates Aurora-A localization. Biochemical and Biophysical Research Communications. 370(2). 213–219. 19 indexed citations

14.

Pugacheva, Elena N., Sandra A. Jablonski, Tiffiney R. Hartman, Elizabeth P. Henske, & Erica A. Golemis. (2007). HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium. Cell. 129(7). 1351–1363. 687 indexed citations breakdown →

15.

Poulikakos, Poulikos I., et al.. (2006). Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. Oncogene. 25(44). 5960–5968. 137 indexed citations

16.

Robbins, A R, Sandra A. Jablonski, Tim J. Yen, et al.. (2005). Inhibitors of Histone Deacetylases Alter Kinetochore Assembly by Disrupting Pericentromeric Heterochromatin. Cell Cycle. 4(5). 717–726. 89 indexed citations

17.

Liu, Song‐Tao, James C. Hittle, Sandra A. Jablonski, et al.. (2003). Human CENP-I specifies localization of CENP-F, MAD1 and MAD2 to kinetochores and is essential for mitosis. Nature Cell Biology. 5(4). 341–345. 131 indexed citations

18.

Chan, Gordon K., Sandra A. Jablonski, Daniel A. Starr, Michael L. Goldberg, & Tim J. Yen. (2000). Human Zw10 and ROD are mitotic checkpoint proteins that bind to kinetochores. Nature Cell Biology. 2(12). 944–947. 171 indexed citations

19.

Jablonski, Sandra A., Gordon K. Chan, Carol Cooke, Tim J. Yen, & William C. Earnshaw. (1998). The hBUB1 and hBUBR1 kinases sequentially assemble onto kinetochores during prophase with hBUBR1 concentrating at the kinetochore plates in mitosis. Chromosoma. 107(6-7). 386–396. 154 indexed citations

20.

Rozhon, Edward J., Stuart Cox, Peter Buontempo, et al.. (1993). SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. Antiviral Research. 21(1). 15–35. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact